Table 3.
Comparison of hematologic parameters within and between two groups after cycle 8.
| Parameters | FMD group (n = 22) | Control group (n = 22) | P ¶ | ||||
|---|---|---|---|---|---|---|---|
| Baseline | After cycle 8 | P* | Baseline | After cycle 8 | P* | ||
| RBC (×106/μl) | 4.22 ± 0.53 | 4.06 ± 0.37 | 0.007 | 4.12 ± 0.48 | 3.79 ± 0.34 | 0.01 | 0.01 |
| HG (g/dl) | 12.39 ± 0.79 | 12.15 ± 0.72 | 0.01 | 12.45 ± 0.79 | 12.21 ± 0.74 | 0.006 | 0.83 |
| WBC (×103/μl) | 4.86 ± 0.73 | 4.55 ± 0.92 | 0.006 | 4.91 ± 0.77 | 4.56 ± 0.93 | 0.004 | 0.94 |
| PLT (×103/μl) | 302.72 ± 45 | 316.77 ± 54.1 | 0.03 | 305.5 ± 44.5 | 322.04 ± 53.1 | 0.01 | 0.74 |
| NEUT (×103/mm3) | 4.61 ± 0.65 | 3.98 ± 0.48 | 0.001 | 4.57 ± 0.73 | 3.58 ± 0.31 | 0.001 | 0.002 |
Data presented as Mean (SD). *Within group (comparing between baseline and after cycle 8), Paired t-test was used. ¶Between group (comparing between FMD group and control group), independent t-test was used. RBC, red blood cells; HG, hemoglobin; PLT, platelets; WBC, white blood cells; NEUT, neutrophils.